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Background: Genome-scale RNA-interference (RNAi) screens are becoming ever more common gene discovery
tools. However, whilst every screen identifies interacting genes, less attention has been given to how factors such
as library design and post-screening bioinformatics may be effecting the data generated.
Results: Here we present a new genome-wide RNAi screen of the Drosophila JAK/STAT signalling pathway
undertaken in the Sheffield RNAi Screening Facility (SRSF). This screen was carried out using a second-generation,
computationally optimised dsRNA library and analysed using current methods and bioinformatic tools. To examine
advances in RNAi screening technology, we compare this screen to a biologically very similar screen undertaken in
2005 with a first-generation library. Both screens used the same cell line, reporters and experimental design, with
the SRSF screen identifying 42 putative regulators of JAK/STAT signalling, 22 of which verified in a secondary screen
and 16 verified with an independent probe design. Following reanalysis of the original screen data, comparisons of
the two gene lists allows us to make estimates of false discovery rates in the SRSF data and to conduct an
assessment of off-target effects (OTEs) associated with both libraries. We discuss the differences and similarities
between the resulting data sets and examine the relative improvements in gene discovery protocols.
Conclusions: Our work represents one of the first direct comparisons between first- and second-generation
libraries and shows that modern library designs together with methodological advances have had a significant
influence on genome-scale RNAi screens.
Keywords: Genome screening, RNAi, Off-target effect, JAK/STAT pathway, Functional genomics, dsRNABackground
The identification of RNAi and its implementation in cell
culture has made systematic approaches to reverse-genetic
screens a possibility [1]. Genome-wide RNAi screens in
Drosophila cell lines, have identified genes involved in key
cellular signalling pathways, such as Notch, JAK/STAT and
Ras/MAPK [2-5]. However, major challenges are still asso-
ciated with this kind of large-scale screening approach.
Firstly, the failure to identify regulators (false negatives),
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reproduction in any medium, provided the ortype specific effects. Generally, false negative effects are un-
likely to confound data processing. However, failure to
identify genes that regulate the process of interest ultim-
ately represents ‘lost’ information, which is thus not avail-
able for future analysis. The frequency of such false
negatives can be reduced by improved reagent design and
using multiple, independent RNAi reagents per gene [6,7].
The second challenge is the mistaken identification of genes
- false positives that incorrectly appear to interact due to
edge effects, liquid handling errors or the non-specificity of
reagents (known as off-target effects (OTEs); [8,9]). Such
false positives can make up more than 50% of primary
screen data [6], are likely to confound initial analysis and
can only be fully eliminated by downstream secondary
screening and gene analysis in vivo.
One way to reduce the rate of false positives is via
improvements in library design. Significant progress hastd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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first-generation libraries such as the Heidelberg Fly
Array (HFA) and Drosophila RNAi Screening Center
(DRSC) v1.0 resources [10]. Current second-generation
libraries, such as the Heidelberg HD2 library, generated
by the Boutros (Heidelberg) and Kiger (UCSD) labs,
have been designed to avoid OTEs predicted at the 19-
nucleotide (nt) level. Indeed, a recent study reported that
37.1% of the first-generation HFA library dsRNAs con-
tain potential OTEs, compared to 26.6% of HD2 library
reagents [11]. Modern libraries also avoid repetitive ele-
ments, such as tandem repeats of the trinucleotide CAN
(where N indicates any base) [8,12] with the frequency
of dsRNAs that include CAN repeats being reduced
from 5.3% in the HFA library to 0.5% in the second-
generation HD2 library [11].
In addition to in silico design considerations, a number of
additional advances have also been incorporated into the
second-generation HD2 library. These involve a novel sys-
tem of primer adaptors designed to minimise the chances
of inter-well contamination and the use of dsRNAs target-
ing DIAP1/thread which are included in a pattern of wells,
known as a ‘bar code’, unique to each library plate. DIAP1
knockdown results in a strong cell death phenotype [13]
and as a consequence, the pattern of ‘dead’ wells allows the
post-screen identification of each library plate on the basis
of cell survival (Additional file 1A) as well as serving as an
indicator of dsRNA uptake and efficacy.
Although the use of second-generation libraries such
as HD2, or the equivalent DRSCv2.0 [14], should give
improved data quality, no published experimental ana-
lysis has been carried out to quantify these improve-
ments using biologically comparable screens.
One of the few signalling pathways where multiple
genome-wide RNAi screens have been completed, is the
Drosophila JAK/STAT signalling pathway, where two
first-generation library screens have been published
[15,16] as well as a more recent screen using a custo-
mised commercial library [4]. These screens used differ-
ent luciferase-based transcriptional reporters, cell lines
and pathway stimulation protocols as well as significantly
different bioinformatic post-screen processing (reviewed
in [17]). Although all screens identified a number of core
pathway components, the overlap of hits from the two
first-generation screens was surprisingly small. However,
the significant differences between the experimental
approaches used prevent any systematic identification of
factors responsible for the differences in gene lists ultim-
ately identified. Indeed, low levels of overlap have also
been reported for NF-κB signalling, which has also been
repeatedly interrogated by RNAi screens, likely due to
differences in reporters and cell types used [18].
For direct comparison of first- and second-generation li-
braries to be possible, identical screens using each libraryin parallel are required. However, due to the replacement,
and hence the unavailability, of first-generation libraries
this is no longer possible. Nonetheless, valuable compari-
sons can be made by comparing a substantively ‘similar’
screen to the data produced from a previous first-
generation screen. Here we describe data derived from a
new genome-wide RNAi screen for regulators of Upd-
activated JAK/STAT signalling. This screen was under-
taken using the HD2 second-generation dsRNA library as
transcribed and reformatted in the Sheffield RNAi Screen-
ing Facility (SRSF). This screen is biologically as similar
as possible to a previous screen undertaken using the
first-generation HFA library [16]. We have analysed our
new dataset using a defined set of rules employed by the
SRSF as a standard, reproducible approach to screen
analysis. These rules take advantage of the CellHTS2 R/
Bioconductor package [19]. We have also used these
rules to retrospectively reanalyse the original HFA
screen-derived primary data, in order to eliminate dif-
ferences in data processing from our comparison. We
compare the results of the HFA- and HD2-derived
screens and use these to both identify the genes
involved in regulating JAK/STAT signalling and also to




Ideally, a direct comparison of RNAi library designs
would utilise two screens undertaken at the same time
and in parallel that differ only in the libraries used.
However, since the re-synthesis of a first-generation li-
brary to undertake such a direct comparison is not prac-
ticable, we set out to replicate a well-defined and
previously published screen for which raw data was
available. We therefore undertook a JAK/STAT RNAi
screen modelled on a previous report carried out in
2005 using the first-generation HFA library (summarised
in Figure 1A. See also Methods and [16] for details).
The principal differences between the original HFA and
the repeated SRSF screen relate to the libraries used, and
whilst the most obvious difference is to the sequences of
the dsRNAs that make up the library itself, other factors
may also be significant. For example, the plate layouts of
the original HFA library (Additional file 1B) included 4
spaces per plate, which were used for controls targeting
three positive pathway regulators (dome, hop, Stat92E)
and the negative regulator (Socs36E). By contrast, the HD2
library was reformatted to allow additional duplicated con-
trols as part of the library amplification undertaken at the
SRSF (Additional file 1A) - changes that support inde-
pendent statistical estimates of the required number of
controls per plate [20]. This reformatted library is hence-
forth referred to as SRSFv1. Secondly, in order to add
Figure 1 Workflows of JAK/STAT RNAi screening methods and data analysis. (A) Workflow of setting up the RNAi screen. Green boxes
indicate steps carried out under sterile culture conditions. (B) Workflow of data analysis of genome RNAi data. Pink boxes indicate steps requiring
manual data assessment and visualisation while grey boxes represent automated steps.
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the new screen was repeated in triplicate, in contrast to
the HFA screen, which was carried out in duplicate. For
both HFA and SRSF screens, replicates were considered to
be biologically independent of one another with a new
batch of transfected cells used for each copy of the
genome.
Given the differences in the libraries used, efforts were
made to reproduce the biology of the original screen as
closely as possible. Firstly, Drosophila Kc167 cells were
batch transfected with the same quantities of a STAT92E-
dependent transcriptional reporter (6x2xDRafLuc), path-
way ligand to stimulate JAK/STAT pathway signalling
(pAc-Upd-GFP) and a constitutive Renilla Luciferase re-
porter (pAc-RLuc), used to assess cell viability. Although
the Kc167 cells used are derived from the same original
source, precise matching of age and passage number be-
tween both screens could not be controlled. However, ex-
perience has shown that Kc167 cells are biologically stablewith no detectable differences observed in their response
to JAK/STAT signalling over at least 15 passages (data not
shown). Following transfection, cells were transferred into
library plates using automated liquid dispensers, and
knockdown was allowed to occur over 5 days. Following
cell lysis, luminometric substrates were added to measure
both the Firefly Luciferase (FL) and Renilla Luciferase
(RL) channels using a plate reader (Figure 1A).
Data analysis
Many statistical methods are available for hit identifica-
tion from large-scale screen data [21-23]. To be able to
make comparisons between our SRSFv1-derived gen-
ome-wide screen and the original HFA screen, we ana-
lysed both raw datasets using the current ‘best practice’
SRSF analysis workflow (Figure 1B). All raw data was
initially processed using the standard protocol for
dual-luciferase based screens in the CellHTS2 package
of R/Bioconductor [19]. This allows an initial assessment
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tered data. Luciferase intensity ratios (FL/RL) were nor-
malised by intra-plate median centering, then scored for
significance using the robust Z-score (Z = x-median/
MAD). In this approach the median absolute deviation
(MAD) represents a measure of variation within the data-
set that is less sensitive to outliers than other measures,
such as standard deviation.
In the first instance, controls included on each screen-
ing plate were assessed to determine the biological ef-
fectiveness of both screens (Figure 2A and 2B). In both
screens positive controls known to be required for JAK/
STAT signalling are recovered. Furthermore, the add-
itional space available for controls in the SRSFv1 library
also allows for technical controls (RLuc, which targets
Renilla luciferase mRNA and thus skews the FL/RL
ratio, and GFP, which targets the Upd-GFP mRNA) and
the negative control (C.elegans dsRNA ZK686.3) to be
added (Figure 2B). In addition, the effect of inter-plate
and inter-replicate effects were also assessed using box
and whisker graphs plotted for each plate (Additional
file 2). When compared in this manner, the SRSFv1 data
appears to be highly consistent - with the exception of
plates 38 and 53 in replicate 3 (Additional file 2E, aster-
isks). By contrast, the HFA data shows considerably
more variation between plates, a characteristic that
often spans both replicates (Additional file 2A and 2B,
asterisks).
Having confirmed that the controls had worked at a
technical level, the Z-scores of each experimental repli-
cate were then averaged and visualised as heat maps to
identify technical errors whose inclusion would other-
wise lead to false positives. For example, liquid handling
errors on plates 38 and 53 of the SRSF screen
(Figure 2D) and edge effects in rows A and B of several
plates in the HFA screen (Figure 2C) are readily identi-
fied by human eye. In cases where liquid handling errors
are identified, individual replicate data is examined to
discover the source of the error. These evaluations, to-
gether with the known positions of control wells, are
added to a ‘screen log’ file, a feature of the CellHTS2
package that allows wells to be excluded from down-
stream analysis. Following removal of the wells listed in
the screen log file, Z-scores for the remaining wells are
recalculated and plotted as heat maps which now show
only interacting dsRNAs (Figure 2E and 2F). Significance
was considered in wells with average FL/RL Z-scores
greater than 2.0 or less than -2.0 (representing an
equivalent p-value of <0.05; Figure 1B). However, it
should be noted that while the triplicate data of the
SRSF screen means that errors present in a single
offending replicate could be removed (Figure 2F), the re-
moval of edge effects in the HFA data leaves only one
(or sometimes zero) remaining data point(s) (Figure 2E).Although not optimal, the number of wells excluded
from the HFA dataset for this reason are included in
Table 1 to facilitate inter-screen comparisons.
Analysis to this point has only considered the FL/RL
ratios of potential interactions. This is a consequence of
the screen design that uses a reporter constitutively
expressing Renilla luciferase (RL) as a proxy for cell
number. The prediction being that in a situation where
JAK/STAT pathway activity is unaffected but cells under
proliferate, both FL and RL channels are proportionately
reduced with the FL/RL ratio remaining constant. How-
ever, this ‘biological normalisation’ relies on luciferase
expression, activity and detection of both channels chan-
ging linearly with respect to one another. In cases where
linearity is not perfect or values in either channel are ex-
treme, the resulting FL/RL Z-score ratio can indicate a
potentially misleading significant change (see Additional
file 3). To visualise this relationship between the FL and
RL signals, we plotted FL and RL channels separately for
each screen (Figure 3), an approach that clearly visua-
lises the effect of the controls used on both FL and RL
channels (Figure 3C and 3D). Generally acting as antici-
pated, the pathway regulators (hop, dome, Stat92E,
Socs36E and Ptp61F) effect the FL channel, but not on
the RL channel (blue and red in Figure 3D), while the
technical control targeting the Renilla luciferase mRNA
has the inverse effect reducing RL levels but having no
effect on FL (purple in Figure 3D). By contrast, the DIAP1
control effects both channels (brown in Figure 3D),
while the non-interacting control ZK686.3 lies within
the main cluster of samples (yellow in Figure 3D). We
also visualise wells that were excluded due to edge
effects or liquid handling errors during the initial data
visualisation (triangles in Figure 3C and 3D). While
many of these excluded wells cluster within the middle
of the graphs (0,0), some are clearly outliers that may
have been selected as putative hits without this level of
analysis.
Although the biological and technical controls act as
anticipated, we noticed that knockdown of a subset of
genes initially characterised as hits actually show large
RL Z-scores, but largely unaffected FL values (outlined
in red in Figure 3F). Furthermore, visual monitoring of
these wells in subsequent re-screens did not suggest that
this increase in RL activity was a consequence of
increased cell number (data not shown). Closer examin-
ation of the predicted biological ontologies of these
genes identified multiple heat-shock proteins and com-
ponents of the proteolysis pathway (Additional file 3).
As such, it is likely that this interaction is actually a re-
sult of changes to Renilla Luciferase protein stability
and/or activity. As such, additional steps to identify false
positive signals arising from large (and potentially arte-
factual) changes in the RL signal are also necessary.
Figure 2 Visualisation of whole genome data is required for error identification. (A-B) Box and whisker plots show the averages and
variance both of the whole data set (All Samples) as well as the controls used in the HFA screen and SRSF screens. GFP RNAi resulted in only a
weak decrease in signalling, due to the high levels of Upd-GFP produced in the transfection. Failure of notches to overlap suggests that the two
medians are significantly different. Y-axis shows Z-scores. (C-F) Heat maps representing Z-scores of FL/RL normalised values for the HFA screen (C
and E) and the SRSF screen (D and F), in unfiltered format (C and D) and after filtering of controls and errors (E and F). As shown in the key,
blues represent a decrease in pathway activity while reds indicate an increase.
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hit selection criterion based on single channel data as a
tool to identifying cell density artefacts misidentified as
hits (Figure 1B). This additional selection rule requires
wells with a significant FL/RL Z-score ratio in at least
two replicates to also have significant Z-scores for the
FL channel alone, while simultaneously not showing a
significant Z-score in the RL channel (Figure 1B).
Following data analysis as described above and visually
represented in Figure 1B, the SRSFv1 screen identified
42 putative hits representing 20 positive regulators and22 negative regulators of pathway signalling (Table 2,
Additional file 4). By contrast, reanalysis of the original
HFA screen data using the same set of rules identified
134 putative regulators of pathway signalling (111 posi-
tive and 23 negative regulators; Additional file 5). The
overlap between these groups and potential explanations
for differences between them are examined below.
Screen comparison
Our analysis of the SRSFv1 screen and our reanalysis of
the original HFA data set identified the known ‘core’
Table 1 HFA and SRSF genome coverage and hit selection
HFA screen SRSF screen
FlyBase r2.0 FlyBase r5.24
Nr Genes % of genome Nr Genes % of genome
Initial Library coverage 13,226 88.8% 14,587 97.9%
Genes excluded due to screening errors (Figure 1B, step 2) 820 6.2% 0 0.0%
Remaining genome coverage 12,406 83.3% 14,587 97.9%
Genes with significant Average FL/RL (Figure 1B, step 4) 1,161 7.8% 300 2.0%
Final hits after applying all hit selection rules (Figure 1B, step 6) 134 0.9% 42 0.3%
The number of genes and % of the r 5.24 genome (14,898 genes) this represents are shown for each stage of the analysis pipeline. Genome annotation release
used in the design of each library is indicated.
Figure 3 Analysis of separate luciferase channels Scatter plots showing Z-scores of RL vs FL channels for HFA screen (A, C, E) and SRSF
screen (B,D,F). Wells from the screen log files, used to exclude data from the analysis, are shown for the HFA (C) and SRSF (D) screens. The
positions of wells containing the indicated control dsRNAs are indicated in their corresponding colours, while grey triangles signify wells with
errors or empty of dsRNA. (E and F) Show fully filtered data for each screen.
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Table 2 Hits identified in SRSF RNAi screen and overlap with other screens
Row Gene SRSF genome SRSF secondary HFA genome Tertiary screen (independent dsRNAs)
1 dome -7.9 -7.1 -8.0 -6.7
2 Stat92E -6.8 -11.4 -6.5 -6.8
3 hop -5.7 -10.0 -2.6 -4.4
4 mask -4.3 -6.6 -3.8 NS
5 Mov34 -3.2 -4.1 -3.0 0.1
6 RpL24 -2.6 -2.5 -6.8 0.1
7 Ptp61F 2.3 3.6 5.0 4.1
8 CKIalpha 4.1 2.6 4.8 2.5
9 chinmo 6.6 4.8 7.0 2.7
10 TfIIA-L -3.8 -5.5 -1.8 # NS
11 Chd1 -2.2 -1.7 # -2.4 NS
12 Saf-B 2.5 1.8 # 4.6 NS
13 Socs36E 2.8 1.8 # 2.5 3.9
14 shrb 2.3 3.0 NA1 -0.4
15 dom -3.4 -2.4 NA2 0.9
16 RpLP2 -2.4 -2.2 NA2 -0.5
17 CG7185 2.6 1.7 NA3 1.6
18 RpII215 -2.2 -2.2 NA3 -1.1
19 Dp -2.2 -2.8 -2.8 * -0.8
20 CG32269 -3.1 -1.7 # -1.7 * 0.2
21 E2f -3.1 -4.9 -1.0 -1.3
22 CG11873 2.2 2.2 0.0 2.5
23 TSG101 2.3 6.0 1.6 -1.1
24 ftz-f1 2.3 2.7 0.5 2.0
25 kis 2.3 2.5 0.9 0.0
26 lola 3.1 4.0 -0.8 -1.1
27 srp 8.6 8.5 -0.5 NS
28 ctrip -2.6 -1.9 # 0.0 -1.1
29 ham 4.5 1.8 # -0.5 1.7 #
30 Tbp -4.5 0.5 -1.3 -2.0
31 CG41021 -3.6 -1.1 1.4 -3.3
32 Dcp2 -2.0 -0.6 -0.6 -0.4
33 CG9723 -2.0 1.3 -0.5 0.0
34 pcnr017:3R -2.0 -0.4 1.2 -0.4
35 Cnot4 2.1 0.7 0.5 0.4
36 qkr54B 2.2 0.4 0.3 0.7
37 l(3)mbt 2.6 0.5 -0.4 0.8
38 Hsp60B 2.7 0.1 0.0 0.0
39 Sin 2.7 1.2 1.5 -0.1
40 CG11399 2.8 1.4 0.3 0.2
41 Surf4 3.1 0.8 1.3 -0.7
42 zfh1 5.2 0.8 0.6 0.6
Bold = Z-score <-2 or >2, # = Z-score <-1.7 or >1.7, * = only one replicate significant, NA = Excluded due to edge effects (1), error (2), error in one rep (3),
NS = Not screened since previous clones are already independent designs.
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JAK kinase hop and the Stat92E transcription factor as
well as the negative regulator Socs36E and the tyrosine
phosphatase Ptp61F (Table 2). However, despite the com-
monality at the level of the core pathway components,
only 12 (29%) of the SRSF hits were also present in the
reanalysed HFA data (Table 2, rows 1–13). The relatively
small overlap between these apparently biologically similar
experiments is unexpected given that the principal differ-
ences between the SRSF and HFA screens are the libraries
used and the number of replicates screened. In addi-
tion, we found that an even lower overlap, only 6 hits
(Additional file 6), occurred between the SRSF and Baeg
screens [15], a study undertaken using different reporter,
cells and pathway activation methodologies. We therefore
examined the HFA data relating to each of the 42 regula-
tors identified in the SRSF screen to better understand
why they were not selected as hits. Firstly, despite the
reduced genome coverage of the HFA library, dsRNA
designs targeting each of the 42 genes were present within
the original HFA library. However, five of these genes were
excluded, in one or both replicates, due to edge effects or
liquid handling errors (marked NA in rows 14–18 of
Table 2). Since our analysis rules require that at least two
replicates must be significant, removal of one replicate in
the HFA screen prevented the classification of these genes
as a hit. A further two HFA targets gave significant, or
close to significant, Z-scores (Table 2, rows 19–20) in only
one replicate, a distribution that does not meet the cut-off
criteria and so leads to these not being formally consid-
ered hits. As such, it is possible that the failure to identify
these 7 genes is at least partly attributable to the lack of
a triplicate dataset in the original HFA screen. The
remaining 23 genes identified from the SRSF library, while
present in the HFAs collection, were not found to be sig-
nificant in the HFA screen (Table 2, rows 21–42).
To gain insight as to whether the 42 putative hits identi-
fied in the original SRSF screen represent false negatives
from the HFA screen or false positives within the SRSF
screen, we selected each of the 42 dsRNA PCR clones
from the SRSF library, re-synthesised dsRNA and re-
arrayed these with multiple non-interacting controls and
rescreened using the same triplicate assay (Figure 1A).
However, in this case, the large proportion of interacting
wells present led us to modify data analysis by calculating
Z-scores from the median of the non-interacting controls,
rather than the whole plate (see Materials and Methods
for details). Analysis of these repeated primary dsRNAs in-
dicate that 22 of the original 42 hits are reproducibly sig-
nificant in this assay (Bold in Table 2), with a further 7
trending in the same direction as the genome score with
Z-scores <−1.7 or >1.7 (Hashes in Table 2).
Based on this secondary screen using the original
dsRNA designs up to 29 genes represent potentially ‘truepositives’ while 13 genes were not re-identified and so
may represent false positives. This represents a potential
false positive rate of 31%. Consistent with this classifica-
tion, none of the putative false positive hits from the ini-
tial SRSF screen were found to be significant in the
reanalysed HFA screen (Row 30–42 in Table 2). Consid-
ering only the validated hits identified in SRSF screens
(Table 2 Rows 14–18) up to 68% of genes were also
identified, or missed due to screening limitations, in the
original HFA screen.
Tertiary screening
While re-screening the original dsRNAs should elimin-
ate technical variations, it does not provide an insight
into the fidelity of the dsRNAs themselves. We therefore
designed new dsRNAs targeting 37 of the 42 genes that
were originally identified on the basis of a single dsRNA
design (the remaining 5 having already been targeted by
two independent dsRNAs present within the libraries
are labelled NS [not screened] in Table 2). These new
designs were generated by the E-RNAi tool [24] used to
design the second-generation SRSF library but exclude
the gene regions previously targetted (Additional file 5).
Following dsRNA synthesis and quality control, this new
set of reagents was used to undertake a tertiary re-
screen using the same protocol already described. Fol-
lowing analysis, the core pathway components dome,
Stat92E and hop were all re-identified as strong interac-
tors as were the negative regulators Socs36E, Ptp61F,
CkIalpha and chinmo (Table 2). In total, 16 of the 42
hits (38%) were found to significantly interact with JAK/
STAT signalling with two independent dsRNA reagents
per gene. However, 15 of the new dsRNAs failed to
interact significantly despite the original dsRNAs having
been re-identified in both the original and secondary
screen. The genes that were not re-identified include
TSG101, a component of the endocytic trafficking ma-
chinery whose influence on JAK/STAT signalling has
been previously examined in detail [25]. By contrast, the
15 genes that failed to interact also include two riboso-
mal proteins (RpL24 and RpLP2) and the Polymerase II
subunit RpII215, genes unlikely to represent JAK/STAT
pathway-specific interactors.
Tertiary screening also provided insights into the 13
genes only identified in the primary genome-scale screen
(rows 30–42 in Table 2). Two genes (Tbp and CG40121)
were re-identified in the tertiary screen – suggesting that
these are in fact legitimate regulators and false negatives
in the secondary screen. While the weight of evidence
suggests that the remaining 11 genes were primary false
positives, it remains possible that genuine interactors re-
main. For example, Cnot4 has previously been shown to
act as a pathway regulator in S2 cells and has been vali-
dated using cell-based and in vivo assays [26]. Taken
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specific effects of the original library, but also the poten-
tial for reagent efficiency and experimental variability to
confound results in this class of experiment.
To clarify whether similar inconsistencies occurred
within the HFA library, we also re-screened independent
dsRNA reagents targeting 126 of the 134 hits from the
HFA genome-wide screen. We were unable to design, or
had previously screened and found to be significant,
independent reagents targeting the remaining 8
(Additional file 5). Fifty of the independent designs were
picked as PCR templates from the SRSFv1 library, and
the remaining 77 were newly designed. Of the 128 genes
screened with two independent dsRNAs, only 8 showed
an interaction consistent with the HFA genome-wide
data, with a further 4 trending in the right direction
(Additional file 5). This remarkably low overlap of only
6%, suggests that a large proportion of the HFA ‘hits’
were due to non-specific effects.
Off-target analysis
Although RNAi reagents can behave with high specificity
in Drosophila cells, as previously shown by microarray
experiments [27], OTEs can represent a potential source
of false positive hits in RNAi-based experiments. How-
ever, modern in silico library design approaches are be-
ginning to reduce their impact and in silico off-target
prediction approaches suggest that only 26.6% of the
dsRNAs that make up the HD2 library have potential
OTEs at the 19-nt level, compared to 37.1% in the first-
generation HFA library [11]. We have used the data
from the HFA and SRSF JAK/STAT screens, and the
predicted OTEs for each of these hits, to investigate this
further. Firstly, the 134 hits found in the HFA reanalysis
and the 42 hits from the SRSF genome screens have a
similar frequency of one or more predicted OTEs, 44.8%
v. 44.1%, respectively. To define whether these potential
OTEs could influence the identification of interacting
genes, we generated a list of interacting dsRNAs, their
primary intended targets and their potential off-targets
as predicted at the 19-nt level by NEXT-RNAi [11]. We
then investigated whether any of these predicted off-
targets appear as primary hits in either of the two
genome screens. Such a scenario would suggest that the
interaction of the original dsRNA might be a conse-
quence of the off-target and thus represent a false posi-
tive JAK/STAT pathway regulator. Of the 134 genes (136
dsRNA clones) identified from the HFA screen, we
found that 10 have predicted OTEs that target a gene
identified in either screen (7.4%) (Table 3). By contrast,
of the 42 genes (43 dsRNA clones) in the SRSF hit list,
only one dsRNA had predicted off-targets that were also
hits in one of the screens (2.3%) (Table 3). This indicates
that while a similar number of clones with potentialOTEs are identified in the primary screens, those whose
OTEs are likely to have effected the final outcome are
less frequent in the SRSF-derived data.
The frequency of interacting OTEs found in our
screen is either a random effect or a consequence of se-
lection imposed by the screen itself. To investigate this,
we randomly selected 100 dsRNAs from each library
and counted how many of the associated predicted off-
targets appear within the same list of 100 primary gene
targets. After 1000 such search iterations, we find that
the SRSF library has significantly fewer ‘circular’ OTEs
(0.5%) compared to the HFA library (3.4%), a result that
demonstrates the improvements in the SRSF/HD2 li-
brary design. However, this random ‘background’ chance
of circular OTEs is significantly lower than the actual
rate of potential OTEs found in our gene lists and sug-
gests that the biological selection imposed by a screen is
a more important factor in determining the frequency of
OTEs encountered in practice.
Conclusions
Here we present the results of a screen undertaken at
the Sheffield RNAi Screening Facility (SRSF), one of only
a handful of Drosophila RNAi screening facilities open
to external screeners [28]. In order to be able to qualita-
tively evaluate the performance of the second-generation
SRSFv1 library used at the SRSF we set out to replicate a
previous genome-wide RNAi screen designed to identify
regulators of the JAK/STAT signalling cascade [16]. This
original screen used a first-generation library of dsRNAs
(Table 1) and identified interacting loci that have since
been extensively investigated and validated [29], includ-
ing the phosphatase Ptp61F and the positive regulator
BRWD3 [16]. Given the provenance of the original gene
list, we therefore expected the SRSF screen results to
correlate closely, especially given that both data sets
were analysed using equivalent bioinformatic rules
within this study (Figure 1B). Indeed, the technical qual-
ity of the triplicate SRSF screen data appears to be very
high (Additional file 2C-E), and represents a significant
improvement over the original HFA data (Additional file
2A-B, also compare Figure 2C and 2D). Furthermore,
the triplicate data set allows a degree of robustness in
downstream rejection of edge effects and similar arte-
facts unavailable to the duplicated HFA data, an obser-
vation that provides confidence in the veracity of the
SRSF results generated.
Surprisingly however, initial comparisons of the SRSF
and HFA screen results suggested that as little as 29%
(12 of 42) of the SRSF hits were common to both. Fol-
lowing secondary screening of the 42 genes initially
identified by the SRSF genome-wide screen, only 22
genes were re-identified at high confidence levels, repre-
senting a 48% false positive rate for the SRSF screen. A
Table 3 Off-target analysis of HFA and SRSF hit lists















HFA16984 larp -3.1 FBgn0003013 osa HFA17022 -4.2 *
HFA18710 RpS14a -6.1 FBgn0004404 RpS14b HFA18711 -4.9 *
HFA19901 CG4411 -2.3 FBgn0039633 CG11873 BKN26700 2.2
FBgn0028991 CG4055 HFA06863 -3.7 *
FBgn0043884 mask HFA16018 -5.6 *
FBgn0043884 mask HFA16005 -5.8 *
FBgn0043884 mask BKN20625 -4.3 *
FBgn0004656 fs(1)h HFA18778 -4.1 *
FBgn0086902 kis BKN20986 2.3
FBgn0004864 hop HFA20340 -5.8 *
FBgn0004864 hop BKN24272 -5.7 *
HFA12365 Rm62 3.1 FBgn0035720 CG10077 HFA09691 3.1 *
HFA07091 CG8179 4.9 FBgn0020306 dom BKN21379 -3.4
FBgn0015618 Cdk8 HFA11113 -2.3
FBgn0015903 apt HFA04671 3.2 *
FBgn0026575 CG4411 HFA19901 -2.1
FBgn0260794 ctrip BKN20611 -2.6
FBgn0028991 CG4055 HFA06863 -3.7
FBgn0039633 CG11873 BKN26700 2.2 *
FBgn0000008 CG14169 HFA10170 -2.2
FBgn0003013 osa HFA17022 -4.2
FBgn0051716 Cnot4 BKN22063 2.1 *
FBgn0260724 larp HFA16984 -2.9
FBgn0035720 CG10077 HFA09691 3.1 *
FBgn0011666 msi HFA17003 -2.6
FBgn0003507 srp HFA17068 13.6 *
FBgn0003507 srp BKN45799 8.6 *
FBgn0004656 fs(1)h HFA18778 -4.1
FBgn0003687 Tbp BKN20836 -4.5
FBgn0012049 msi HFA17003 -2.6
FBgn0004606 zfh1 BKN29931 5.2 *
FBgn0001078 ftz-f1 BKN28995 2.3 *
FBgn0086902 kis BKN20986 2.3 *
FBgn0034258 CG4954 HFA06905 -5.5
FBgn0027492 CkIIbeta HFA20230 -2.2
FBgn0032633 CG4055 HFA06863 -3.7
FBgn0043884 mask HFA16018 -5.6
FBgn0043884 CG6268 HFA16005 -5.8
FBgn0043884 mask BKN20625 -4.3
HFA06863 CG4055 -4.2 FBgn0015618 Cdk8 HFA11113 -2.3 *
FBgn0000008 CG14169 HFA10170 -2.2 *
FBgn0003507 srp HFA17068 13.6
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Table 3 Off-target analysis of HFA and SRSF hit lists (Continued)
FBgn0003507 srp BKN45799 8.6
FBgn0039633 CG11873 BKN26700 2.2
FBgn0001078 ftz-f1 BKN28995 2.3
FBgn0086902 kis BKN20986 2.3
HFA04671 apt 2.7 FBgn0001078 ftz-f1 BKN28995 2.3 *
FBgn0030636 cngl HFA19089 -2.7
FBgn0003507 srp HFA17068 13.6 *
FBgn0003507 srp BKN45799 8.6 *
HFA18711 RpS14b -6.0 FBgn0004403 RpS14a HFA18710 -4.9 *
HFA17068 srp 8.5 FBgn0030636 cngl HFA19089 -2.7
FBgn0020306 dom BKN21379 -3.4
FBgn0015618 Cdk8 HFA11113 -2.3
FBgn0039633 CG11873 BKN26700 2.2 *
FBgn0260794 ctrip BKN20611 -2.6
FBgn0003016 kis BKN20986 2.3 *
FBgn0086758 CG17156 HFA00485 7.0 *
FBgn0086758 CG17649 HFA00509 7.0 *
FBgn0086758 chinmo BKN45751 6.6 *
FBgn0005630 lola BKN30256 3.1 *
FBgn0000259 CkIIbeta HFA20230 -2.2
FBgn0028371 CG13525 HFA04167 -2.9
FBgn0032633 CG4055 HFA06863 -3.7
FBgn0015903 apt HFA04671 3.2 *
FBgn0026575 CG4411 HFA19901 -2.1
FBgn0001078 ftz-f1 BKN28995 2.3 *
FBgn0011666 msi HFA17003 -2.6
FBgn0028991 CG4055 HFA06863 -3.7
FBgn0035720 CG10077 HFA09691 3.1 *
FBgn0000008 CG14169 HFA10170 -2.2
FBgn0086902 kis BKN20986 2.3 *
HFA09691 CG10077 2.6 FBgn0003261 Rm62 HFA12365 3.8 *
BKN41059 CG40121 -3.6 FBgn0043903 dome BKN25660 -7.9 *
FBgn0000259 CkIIbeta HFA20230 -2.2 *
FBgn0004656 fs(1)h HFA18778 -4.8 *
FBgn0043903 dome HFA19583 -13.5 *
FBgn0010412 RpS19 HFA20281 -7.0 *
Bold and * = labelling of off-targets indicates that their knockdown resulted in a significant Z-score in the same direction as the original intended gene.
On-target dsRNAs with potentially interacting off-targets identified in each screen.
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direction as in the genome-wide screen, whose consider-
ation increases the potential hit list to 29 genes and
decreases the false positive rate to 31%. Taking into ac-
count marginal strength interactions and genes with
missing data it is possible that up to 20 of 29 interacting
loci identified by the SRSF screen were also present in
the original HFA dataset (Table 2), a rate of 68%.Furthermore, even excluding ‘potential’ overlaps where
Z-scores fall just below the -2 cut off, or instances where
not all HFA data is available, an overlap of 60% is still
obtained (12 of 22). By contrast, the levels of overlap to
the larger HFA gene list are smaller. In part this is
expected, as secondary screening of these primary HFA
hits is not possible given the unavailability of the original
HFA library clones. In addition, it is also likely that the
Fisher et al. BMC Genomics 2012, 13:506 Page 12 of 14
http://www.biomedcentral.com/1471-2164/13/506availability of only two data points, together with the
higher levels of experimental noise in the HFA data
(Additional file 2) conspire to increase the rate of false
positives in this primary list.
The tertiary screen used new independent dsRNA
designs targeting 37 of the 42 genes previously targeted
with a single dsRNA (Table 2). Taken together with the
5 genes previously confirmed by multiple dsRNAs, 38%
(16 of 42) of the putative interactors were confirmed by
the tertiary analysis. As expected, this tertiary analysis
also excluded most of the genes previously rejected as
primary false positives by the secondary and HFA
screens. However, tertiary analysis also failed to re-
identify 45% (9 of 20) of the genes identified by primary,
secondary and HFA screens as well as 48% (14 of 29) of
those identified by only the primary and secondary
screens. This relatively low rate of re-identification may
result from either false positive in the original screen or
false negatives in the tertiary. In particular, the design of
the tertiary dsRNAs (Additional file 5), which are
obliged to avoid the regions used by the SRSFv1 dsRNA
designs, may be less efficient and so more likely to gen-
erate false negative results. Despite this, the designs used
in the tertiary screening successfully identified the core
JAK/STAT components, such as dome, hop, Stat92E,
Ptp61F and Socs36E and excluded ribosomal proteins
and core RNA polymerase II subunits unlikely to repre-
sent true positives. Tertiary screening also served to re-
confirm Tbp and CG40121 as bona fide interactors,
genes that were not confirmed in the secondary screens
- presumably due to false negative effects during the sec-
ondary screen. Remarkably, tertiary analysis of the HFA
screen hits revealed that, apart from the core pathway
components mentioned, only 8 genes (6%) were recon-
firmed with independent dsRNA designs (Additional file
5). This suggests that the SRSF library does indeed rep-
resent a significant improvement over this first-
generation library.
Although technical differences in experimental design
undoubtedly play a part in creating these differing hit
lists, a significant factor are recent advances in dsRNA
library design. While the technical background to
second-generation library design has been reported else-
where [11], our work represents one of the first direct
comparisons between first- and second-generation li-
braries. Of particular interest in this respect is the iden-
tification of ‘off-target’ effects that knock down an
unintended secondary mRNA in addition to the primary
‘on’ target. In order to establish a baseline of theoretical
OTEs we repeatedly generated and tested random lists
of library dsRNAs and searched for internal OTEs within
this group. This suggested that a hit list derived from
the HFA library would include 3.4% potential off-target
false positives while the SRSF library would only include0.5% off-target clones. By contrast, our biological data
shows significantly higher off-target rates than predicted
with 7.4% (10 of 136; HFA) and 2.3% (1 of 43; SRSF)
predicted off-target clones being identified (Table 3). We
suggest that this experimentally observed enrichment is
likely to be a consequence of screening itself, with the
search for modulators of JAK/STAT signalling specifically
enriching for genes with OTEs able to modulate pathway
activity. As a consequence, a screen will automatically en-
rich for dsRNAs with interacting OTEs and an increased
frequency of off-target clone identification is largely un-
avoidable and is likely to increase as the assay improves.
This highlights the importance of using improved libraries
optimised to minimise off-target effects and also demon-
strates the utility of post-screen in silico analysis to identify
false positive hits resulting from potential OTEs.
Finally, it should also be highlighted that despite the
apparent reproducibility of the primary SRSF data over
three independent biological replicates, 31% (13 of 42) of
genes initially identified were subsequently classified as
false positives following rescreening. However, two of
these apparently false positives were subsequently re-
identified by tertiary screening and so actually represent
secondary false negatives. The added variability of
dsRNA potency and efficiency, as well as differences be-
tween dsRNA preparations may all play a part in these
inconsistencies. As such, the emphasis on secondary and
tertiary screens, using multiple dsRNA designs, different
assays and using information about the transcriptome of
the cells being screened remains an essential aspect of
any genome-scale experimental design.
Overall, we have established an improved framework for
the design and implementation of RNAi screens using cur-
rently available libraries and analysis methods. In addition,
the iterative process of screening and analysis has refined
our understanding of genes regulating Drosophila JAK/
STAT signalling, revealing novel players in the process.
However, even the most sophisticated screening approaches
are only a tool to identify genes that potentially interact
with a chosen assay system. Ultimately, downstream valid-
ation, analysis and investigation are required to confirm the
true functional and physical nature of the biological net-
works being studied.
Methods
SRSFv1 dsRNA library production
The SRSFv1 library was synthesised at the SRSF, from
PCR products kindly provided by Michael Boutros from
the HD2 collection. Details of the probes used in the
HD2 and SRSF libraries can be found at http://www.
dkfz.de/signaling/nextrnaiData/calc/HD2/out/. Synthesis
was carried out according to [30]. Briefly, PCR products
were amplified using T7 primers using Reddymix (Abgene)
according to manufacturers instructions. PCR products
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Precast Agarose Gels (Invitrogen). Any PCRs that failed to
give a product were repeated. dsRNA was produced using
the T7 MEGAscript Kit (Ambion) according to manufac-
turer’s instructions and incubated for 16 h at 37°C. DNAse
I treatment removed the PCR template and then an
ethanol precipitation was carried out. RNA pellets were
eluted in water, checked by running on a gel and quanti-
fied using a Nanodrop. dsRNA was then diluted in
water 27-fold to a working concentration in the range
20–200 ng/μl. Of this dilution, 5 μl (100 ng – 1 μg) was
added per well of a 384-well plate in each screen.
Screening plates were sealed, with an Agilent PlateLoc
plate sealer, and stored at-80°C until needed. The HD2
library was reformatted to allow for an increased num-
ber of controls per plate. For an example plate layout
see Additional file 1A.
Design of tertiary dsRNAs
Newly designed dsRNAs for tertiary screening were
designed using the E-RNAi webservice v3.2 [24] and are
described in Additional file 5. Original dsRNA regions
were avoided using the options within the web tool.
Cell culture and RNAi screening
Drosophila Kc167 cells were cultured under standard con-
ditions at 25°C, in Schneider’s media (Gibco) supplemen-
ted with 10% FBS (Sigma) and 1% Penicillin/Streptomycin
(Gibco).
For screening, Drosophila Kc167 cells were grown to al-
most confluence in T-75 flasks and were then passaged into
9xT-75 flasks at a density of 40 million cells per flask and
allowed to recover overnight. Cells were then transfected
with 6x2xDRafLuc, pAc-RLuc, pAc-Upd-GFP, and pAc
empty vector as originally described in [16] using Effectene
(Qiagen) according to manufacturers instructions. The cells
were then incubated for 7 h, after which media was
replaced with fresh media lacking serum. Cells were then
seeded into the 384-well library plates, using an automated
liquid dispenser (Multidrop, ThermoFisher), at a density of
15,000 cells per well in 20 μl of serum-free media. After
1 h, 10 μl of media, supplemented with 30% serum, was
added to each well and the plates sealed and incubated for
5 days at 25°C. The genome screen was replicated in com-
pletely separate biological triplicates with an interval of sev-
eral weeks between each replicate.
Luciferase assays
RNAi-mediated knockdown was allowed to occur over
5 days, after which luciferase activity was measured as pre-
viously described [31]. The plates were vibrated for 5 s prior
to reading on a Varioskan (ThermoFisher) plate reader at
100 ms acquisition time per well. The 53 plates containingthe genome were processed in batches of 17 or 18 plates
and data files were produced per channel for each batch.
Data analysis
Statistical analysis was completed using the following
packages: R64 version 2.12.0, biocinstall version 2.7.7, Bio-
conductor version 2.7 and cellHTS2_2.14.0. R scripts were
run on a Mac OS10.6 operating system. The data files were
deconvolved into 318 individual plate .txt files for each fire-
fly and renilla luciferase channel, using a Perl sub-routine,
ready for analysis within the CellHTS2 package in R/Bio-
conductor. Perl and R scripts available on request.
HFA library annotation has been updated, with detailed
information provided at http://www.dkfz.de/signaling/
nextrnaiData/calc/HFA/out/. Data analysis was carried
out as for the SRSF data.
Additional files
Additional file 1: Plate layouts of HFA and SRSFv1 libraries. (A)
Layout of HFA library plates including the position of positive (blue) and
negative pathway regulators, used as controls in the Müller et al. screen.
(B) Layout of SRSFv1 library including the DIAP1 barcode (black), technical
controls (purple), non-interacting controls (yellow) and positive (blue) and
negative (red) pathway regulators used as controls.
Additional file 2: Quality control of HFA and SRSF JAK/STAT screens.
Box and whisker plots representing each plate from separate replicates in
HFA and SRSF screens. Asterisks denote plates where variance can be
observed by eye.
Additional file 3: dsRNAs resulting in high RL values can give
skewed FL/RL ratios. List of genes highlighted in red circle in Figure 3D
have high RL values, many of which have unaffected FL values. All values
are robust Z-scores averaged over three replicates.
Additional file 4: Hits identified in the SRSF screen are also present
in the HFA collection. List of hits identified in SRSF screen, as shown in
Table 2, but including dsRNA amplicon names for SRSF and HFA libraries,
as well as Flybase IDs.
Additional file 5: Tertiary screening results and primer design. List
of the hits identified in both SRSF and HFA screens. Included are Z-scores
calculated from FL/RL ratios and averaged across triplicates, for genome
and tertiary screens. Significance >2 or <−2 highlighted in grey and bold,
significance >1.7 or <-1.7 highlighted in blue and mark #. All sequence
information is included where novel designs were made. Some genes
were not screened (NS) in the tertiary screen either due to inability to
target independent regions, independent regions had already been
screened, or the gene is now withdrawn from Flybase.
Additional file 6: The 6 genes found to be significant in both SRSF
and Baeg screens. Fold change values are shown as originally presented
in ref [15], and +/- indicates an increase or decrease in reporter activity,
respectively. Grey/blue boxes highlight significance levels as indicated in
key.
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